DNA Repair, Helsinki Hospital, Ferrer, Agendia, Power3, Jordan University, Lundbeck, Cogenics, Vermillion, ThinkPanmure, TheraGenetics, Centre for Addiction and Mental Health, Merck, Pfizer, Eli Lilly, PureTech Ventures, Enlight Biosciences, Iverson, DNA | GenomeWeb
DNA Repair Licenses Predictive Breast Cancer Therapy Test from Helsinki Hospital
The DNA Repair Company has licensed the exclusive North American rights to a test from Helsinki University Central Hospital that predicts how women with breast cancer will respond to a common chemotherapy drug.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.